Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy
Clinical trial NCT01510184 · TERMINATED
Trial details
- NCT number
- NCT01510184
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-19
- Primary completion
- 2014-10-23
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.